Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 1/27/2020 6:00:01 PM
Researchers examine social interactions in people with #autism: via @medical_xpress
BCH Innovation News @BCH_Innovation 1/27/2020 4:00:01 PM
Strength training can lead to more than just stronger muscles and bones: via @HarvardHealth
BCH Innovation News @BCH_Innovation 1/27/2020 2:00:02 PM
Clinicians should include #dysmotility in the differential diagnosis of any patient with respiratory symptoms befor…
BCH Innovation News @BCH_Innovation 1/26/2020 8:00:00 PM
Professional guidelines already recommend that #transgender teens be offered #pubertyblockers if they want them:…
BCH Innovation News @BCH_Innovation 1/26/2020 6:00:01 PM
New study reveals that having #fetalsurgery to repair spina bifida is more beneficial for children than having surg…
BCH Innovation News @BCH_Innovation 1/26/2020 4:00:01 PM
Social #anxiety disorder could be linked to an imbalance of #serotonin and #dopamine: via @medical_xpress
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer